Digital healthcare platform MediBuddy raised $40 mn in a Series B funding round led India Life Sciences Fund III, LLC, TEAMFund LP, JAFCO Asia Fund, FinSight Ventures, ALES Global Japan, and Beyond Next Ventures with participation of existing investors including Bessemer Venture Partners, Milliways Ventures, and Rebright Partners.
The company will utilise the funds in further strengthening its doctor and hospital base, patient reach, product, technology, and brand to move a step closer to its mission of providing high-quality healthcare to a billion people. It has a network of over 90,000 doctors, 7,000 hospitals, 3,000 diagnostic centres, and 2,500 pharmacies, covering over 95% of all pin codes in India.
“MediBuddy’s e-health platform enables customers to access the entire gamut of healthcare services — be it teleconsultation services, lab tests, or medicines — across devices. The fund is particularly heartened by MediBuddy’s efforts at enabling such access in vernacular languages, which will be the key to meeting its mission of serving customers across the length and breadth of the country,” explained MDevarajan TP, Managing Director, representative of India Life Sciences Fund III.